The post-antibiotic effects of linezolid against Gram-positive pathogens.

نویسندگان

  • Mine Hosgor-Limoncu
  • Safak Ermertcan
  • Huseyin Tasli
  • Sohret Aydemir
چکیده

OBJECTIVE To investigate the post-antibiotic effect (PAE) of linezolid against methicillin-resistant and -susceptible staphylococci, vancomycin-resistant and -susceptible enterococci. METHODS Clinical strains of Staphylococcus aureus (S. aureus), Staphylococcus epidermidis (S. epidermidis) and Enterococcus faecalis (E. faecalis) were isolated from hospitalized patients at Ege University Medical Faculty Hospital between June and September 2005. This study was made between September and December 2005. The PAE of linezolid was determined at the minimum inhibitory concentration (MIC) and 4 times the MIC concentrations for 60 minutes in Mueller-Hinton Broth (MHB). The duration of the PAE was obtained by following the recovery of bacterial growth in antibiotic free MHB measured colony forming units on Mueller-Hinton agar. RESULTS All the straines were susceptible to linezolid. The PAE was greater at 4 times the MIC (0.5 - 2.4 hours) that at the MIC (0 - 1.7 hours) for linezolid against all organisms tested. The PAE for linezolid was slightly higher against E. faecalis strains than other organisms. CONCLUSION In this study, it was demonstrated that linezolid had a moderate in vitro PAE against S. aureus, S. epidermidis and E.faecalis strains.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Mechanisms of action of newer antibiotics for Gram-positive pathogens.

Certain Gram-positive bacteria, including meticillin-resistant Staphylococcus aureus, vancomycin-resistant enterococci, and quinolone-resistant Streptococcus pneumoniae have achieved the status of "superbugs", in that there are few or no antibiotics available for therapy against these pathogens. Only a few classes of novel antibiotics have been introduced in the past 40 years, and all since 199...

متن کامل

Linezolid--a new option for treating gram-positive infections.

The increase in serious gram-positive infections has increased the need for treatment of gram-positive infections in patients with hematologic malignancies. Common gram-positive pathogens exhibit a variety of resistance mechanisms, and this has supported the need for new antibiotics with unique modes of action and no endogenous resistance mechanism(s) directed against them. Linezolid (Zyvox), t...

متن کامل

Dalbavancin: a novel antimicrobial

The increasing incidence of serious infections because of Gram-positive pathogens and the rising cost in parenteral administration of antimicrobials has inspired the development of a novel antibiotic. Dalbavancin is the first once a week antibiotic with activity against a broad range of Gram-positive pathogens. A large multicentre, pivotal, Phase III clinical trial, which included 854 patients ...

متن کامل

[Oxazolidinones, glycopeptides and cyclic lipopeptides].

A review of the chemical structure, pharmacokinetics, spectrum of activity, clinical use, and adverse effects of oxazolidinones (linezolid), glycopeptides, and cyclic lipopeptides (daptomycin) is presented. Oxazolidinones inhibit protein synthesis, and glycopeptides and cyclic lipopeptides act against the bacterial cell wall. The antibacterial spectrum of these agents covers gram-positive patho...

متن کامل

Clinical update on linezolid in the treatment of Gram-positive bacterial infections

Gram-positive pathogens are a significant cause of morbidity and mortality in both community and health care settings. Glycopeptides have traditionally been the antibiotics of choice for multiresistant Gram-positive pathogens but there are problems with their use, including the emergence of glycopeptide-resistant strains, tissue penetration, and achieving and monitoring adequate serum levels. N...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • Saudi medical journal

دوره 28 4  شماره 

صفحات  -

تاریخ انتشار 2007